226 Supplementary Table S21. Microbiota-associated gene clusters in patients with non-stricturing, non-penetrating disease (Montreal B1) and fibrostenotic CD (Montreal B2) including microbiotaassociated pathway annotation and cluster comparisons. Supplementary Table S22. Genes and bacteria associated with TNF-α-antagonists use (reference: non-users). Supplementary Table S23. Microbiota-associated gene clusters in patients not using and using TNF-α-antagonists includingmicrobiota-associated pathway annotation and cluster comparisons. Supplementary Table S24. Individual pairwise gene-bacteria associations and their interaction with the degree of mucosal dysbiosis (Lloyd-Price et al., Nature 2019). SupplementaryTable S25. Mucosal microbiota and other phenotypic factors explaining variation in mucosal cell type enrichment in patients with IBD. All supplementary tables are available online via the following link: https://doi.org/10.1101/2022.06.04.494807 Chapter 6
RkJQdWJsaXNoZXIy MjY0ODMw